Showing results (211-220 of 289) with videos related to
Sort By:
Pageof 29
AIDS (London, England)|February 1, 1996
The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentinT C Merigan, R L Hirsch, A C Fisher, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1988
Synergistic antitumor activity with IFN and monoclonal anti-idiotype for murine B cell lymphoma. Mechanism of actionT Y Basham, E R Race, M J Campbell, et al.Annals of Internal Medicine|June 15, 1996
The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patientsJ M Schapiro, M A Winters, F Stewart, et al.The Western Journal of Medicine|October 1, 1976
Nosocomial vaccinia infectionR H Johnson, J R Krupp, A R Hoffman, et al.Cancer Research|August 1, 1989
Enhanced in vivo therapeutic response to interferon in mice with an in vitro interferon-resistant B-cell lymphomaT R Reid, E R Race, B H Wolff, et al.Antimicrobial Agents and Chemotherapy|January 1, 1982
Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combinationS L Sacks, G H Scullard, R B Pollard, et al.Arthritis and Rheumatism|November 1, 1981
Treatment of NZB/NZW F1 hybrid mice with Mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune diseaseE G Engleman, G Sonnenfeld, M Dauphinee, et al.Hepatology (Baltimore, Md.)|January 1, 1982
Antiviral treatment of chronic hepatitis B virus infection: infectious virus cannot be detected in patient serum after permanent responses to treatmentG H Scullard, H B Greenberg, J L Smith, et al.Antimicrobial Agents and Chemotherapy|January 1, 1986
Preliminary trial of recombinant fibroblast interferon in chronic hepatitis B virus infectionM Eisenberg, S Rosno, G Garcia, et al.The New England Journal of Medicine|May 4, 1978
Human leukocyte interferon for the treatment of herpes zoster in patients with cancerT C Merigan, K H Rand, R B Pollard, et al.Pageof 29